Eligible AACR 2019 Annual Meeting Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 7 records per page: next > | last >>
pages: 1 2 3 4 5 6 7 presentations: 1 to 25 of 170
from AACR Annual Meeting 2007 on April 15, 2007 7:30 AM-12:15 PM
Issues in cancer prevention research
William G. Nelson, V, M.D., Ph.D.
Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD
from AACR Annual Meeting 2007 on April 14, 2007 8:00 AM-10:00 AM
Using mouse models to develop agents for the prevention of breast cancer
Powel H. Brown, M.D., Ph.D.
Baylor College of Medicine, Houston, TX
from AACR Annual Meeting 2007 on April 14, 2007 8:00 AM-10:00 AM
Experimental compounds impacting translation of chemoprevention studies from mice to humans
David W. Threadgill, Ph.D.
University of North Carolina, Chapel Hill, NC
from AACR Annual Meeting 2007 on April 14, 2007 8:00 AM-10:00 AM
Introduction
Lynda Chin, M.D.
Dana-Farber Cancer Institute, Boston, MA
from AACR Annual Meeting 2007 on April 14, 2007 8:00 AM-10:00 AM
Validating oncogenes as therapeutic targets in conditional transgenic models
Dr. Dean W. Felsher
Stanford University, Stanford, CA
from AACR Annual Meeting 2007 on April 14, 2007 8:00 AM-10:00 AM
Response prediction in engineered models: Using natural variation in preclinical tumor populations to assess the genetic context of drug response
Dr. Murray O. Robinson
AVEO Pharmaceuticals, Inc., Cambridge, MA
from AACR Annual Meeting 2007 on April 14, 2007 8:00 AM-10:00 AM
Acquired drug resistance and kinase addiction: Validating EGFR as a therapeutic target
Dr. Jeffrey Settleman
Massachusetts General Hospital, Charlestown, MA
from AACR Annual Meeting 2007 on April 14, 2007 8:00 AM-10:00 AM
Introduction
Dr. Stephen H. Friend
Merck and Co., Inc., North Wales, PA
from AACR Annual Meeting 2007 on April 14, 2007 8:00 AM-10:00 AM
RNAi screens to identify targets and drug response modifiers
Dr. Peter S. Linsley
Rosetta Inpharmatics LLC, Seattle, WA
from AACR Annual Meeting 2007 on April 14, 2007 8:00 AM-10:00 AM
Systematic siRNA-based HT-RNAi screening in oncology: From discovery and validation of novel targets to drug modifier analyses
Dr. Christophe J. Echeverri
Cenix BioScience GmbH, Dresden, Germany
from AACR Annual Meeting 2007 on April 14, 2007 8:00 AM-10:00 AM
RNAi-based genetic screens to identify novel cancer-related genes
Dr. Rene Bernards
The Netherlands Cancer Institute, Amsterdam, The Netherlands
from AACR Annual Meeting 2007 on April 14, 2007 8:00 AM-10:00 AM
Large-scale RNAi for cancer target discovery and validation
Dr. William C. Hahn
Dana-Farber Cancer Institute, Boston, MA
from AACR Annual Meeting 2007 on April 14, 2007 8:00 AM-10:00 AM
Molecular imaging of spontaneous tumors in genetically engineered mouse models of human cancer
Dr. Jos Jonkers
The Netherlands Cancer Institute, Amsterdam, The Netherlands
from AACR Annual Meeting 2007 on April 14, 2007 10:15 AM-12:15 PM
Emerging approaches and applications of molecular imaging in experimental and clinical oncology
Dr. Martin G. Pomper
Johns Hopkins University, Baltimore, MD
from AACR Annual Meeting 2007 on April 14, 2007 10:15 AM-12:15 PM
Personal financial conflicts of interest among authors of cancer clinical trials and editorials: Scope and relationship to study funding
Dr. Rachel P. Riechelmann
Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada
from AACR Annual Meeting 2007 on April 14, 2007 10:15 AM-12:15 PM
Ethical Framework of Informed Consent in Oncology Trials: A Summit
Susan Samson, MPH
UCSF Breast SPORE Advocacy Core, San Francisco, CA
from AACR Annual Meeting 2007 on April 14, 2007 10:15 AM-12:15 PM
Introduction
Donald A. Berry, Ph.D.
UT M.D. Anderson Cancer Center, Houston, TX
from AACR Annual Meeting 2007 on April 14, 2007 10:15 AM-12:15 PM
Efficient adaptive designs in clinical trials
Donald A. Berry, Ph.D.
UT M.D. Anderson Cancer Center, Houston, TX
from AACR Annual Meeting 2007 on April 14, 2007 10:15 AM-12:15 PM
Practical bayesain adaptive randomization in clinical trials
Dr. Peter F. Thall
UT M.D. Anderson Cancer Center, Houston, TX
from AACR Annual Meeting 2007 on April 14, 2007 10:15 AM-12:15 PM
Using biomarkers in clinical trial design
Dr. Richard M. Simon
NIH-NCI-DCTD, Bethesda, MD
from AACR Annual Meeting 2007 on April 14, 2007 10:15 AM-12:15 PM
Introduction and association of immune cells and cancers
Lisa M. Coussens, Ph.D.
UCSF Comprehensive Cancer Center and Cancer Research Institute, San Francisco, CA
from AACR Annual Meeting 2007 on April 14, 2007 10:15 AM-12:15 PM
Crosstalk between humoral and innate immunity promotes epithelial cancer development
Karin E. de Visser, Ph.D.
The Netherlands Cancer Institute, Amsterdam, The Netherlands
from AACR Annual Meeting 2007 on April 14, 2007 10:15 AM-12:15 PM
Tumor immunity: A balancing act between immune suppression and immune enhancement
Suzanne Ostrand-Rosenberg, Ph.D.
University of Maryland, Baltimore, MD
from AACR Annual Meeting 2007 on April 14, 2007 10:15 AM-12:15 PM
TNF-alpha: A cytokine that links inflammation and cancer
Frances R. Balkwill, Ph.D.
Barts and The London Queen Mary's School, London, United Kingdom
from AACR Annual Meeting 2007 on April 14, 2007 10:15 AM-12:15 PM
<< first | < prev page: of 7 records per page: next > | last >>
pages: 1 2 3 4 5 6 7 presentations: 1 to 25 of 170